Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc.

World Rank (Jan-05-2024)
10,892
Market Cap (Jan-05-2024)
0.662 Billion USD
World Rank (Jul-30-2023)
11,446
Market Cap (Jul-30-2023)
0.614 Billion USD
World Rank (Jan-07-2022)
13,834
Market Cap (Jan-07-2022)
0.472 Billion USD
World Rank (Jan-01-2021)
8,697
Market Cap (Jan-01-2021)
0.840 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
TARS
Market Cap (Mar-08-2026)
3.12
Employee Count
12
Employee Count as of Date
As on June-2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
26 Million USD
Annual Operating Income in USD
-63 Million USD
Annual Net Income in USD
-62 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
227 Million USD
Total Liabilities in USD
35 Million USD
Total Equity in USD
192 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Pharmaceutical
Biopharmaceutical
Healthcare
Biotechnology
Company Website
TARSUS PHARMACEUTICALS, INC.
Company Profile
Tarsus Pharmaceuticals is a Late Clinical Stage Biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address highly prevalent conditions with limited treatment options. It is having 20 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share